Dental amalgam call-for-papers
This article was originally published in The Gray Sheet
Executive Summary
FDA seeks reference information for peer-reviewed journal articles that discuss the health impact of dental amalgam and were published from Jan. 1, 1996 to June 1, 2003. Submissions to FDA are due by June 2. The 1May 9 request is part of FDA's preparation for the latest in a series of literature reviews on the topic that will start later this year. Sponsored by FDA, CDC and the National Institute of Dental & Craniofacial Research, the review will be conducted by an independent group. Prior reviews concluded that, for the most part, dental amalgam poses no serious health threat. Last month, however, Rep. Diane Watson (R-Calif.) introduced 2HR 1680, a bill seeking to ban use of mercury fillings introduced into interstate commerce after 2008...
You may also be interested in...
Dental amalgams
Stakeholders are granted an additional month to send FDA peer-reviewed articles dealing with dental amalgam health risks. Submissions are now due by July 1 (1"The Gray Sheet" May 12, 2003, In Brief)...
EU’s SCCS Finds Endocrine-Disrupting Evidence Inconclusive In UV Filter Reassessments
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
US FDA Urges COVID-19 Transmission Risk Mitigation In Cell And Gene Therapy Manufacturing
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: